vs

Side-by-side financial comparison of Dogness (International) Corp (DOGZ) and Scilex Holding Co (SCLX). Click either name above to swap in a different company.

Dogness (International) Corp is the larger business by last-quarter revenue ($7.7M vs $4.8M, roughly 1.6× Scilex Holding Co). Dogness (International) Corp runs the higher net margin — -67.1% vs -961.9%, a 894.8% gap on every dollar of revenue.

Dogness (International) Corp is a pet product manufacturer focused on designing, producing and selling a broad portfolio of pet care goods, including smart pet feeders, automatic waterers, leashes, collars and grooming tools. Its core markets cover North America, Europe and China, serving both retail consumers and B2B partners in the global pet industry.

Scilex Holding Co is a commercial-stage biopharmaceutical firm focused on developing and commercializing innovative non-opioid pain management therapies for acute and chronic pain segments. It primarily serves the US market, offering prescription and over-the-counter pain relief solutions for patients and healthcare providers.

DOGZ vs SCLX — Head-to-Head

Bigger by revenue
DOGZ
DOGZ
1.6× larger
DOGZ
$7.7M
$4.8M
SCLX
Higher net margin
DOGZ
DOGZ
894.8% more per $
DOGZ
-67.1%
-961.9%
SCLX

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
DOGZ
DOGZ
SCLX
SCLX
Revenue
$7.7M
$4.8M
Net Profit
$-5.2M
$-46.1M
Gross Margin
11.2%
45.5%
Operating Margin
-70.8%
-2317.8%
Net Margin
-67.1%
-961.9%
Revenue YoY
-67.8%
Net Profit YoY
-613.7%
EPS (diluted)
$-0.29
$-4.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DOGZ
DOGZ
SCLX
SCLX
Q4 25
$7.7M
$4.8M
Q3 25
$10.6M
Q2 25
$6.7M
$9.9M
Q1 25
$5.0M
Q4 24
$14.9M
Q3 24
$14.4M
Q2 24
$16.4M
Q1 24
$10.9M
Net Profit
DOGZ
DOGZ
SCLX
SCLX
Q4 25
$-5.2M
$-46.1M
Q3 25
$-257.8M
Q2 25
$-3.2M
$-44.0M
Q1 25
$-26.1M
Q4 24
$-6.5M
Q3 24
$-4.4M
Q2 24
$-37.6M
Q1 24
$-24.4M
Gross Margin
DOGZ
DOGZ
SCLX
SCLX
Q4 25
11.2%
45.5%
Q3 25
68.5%
Q2 25
19.6%
66.9%
Q1 25
72.3%
Q4 24
68.5%
Q3 24
73.9%
Q2 24
73.2%
Q1 24
64.7%
Operating Margin
DOGZ
DOGZ
SCLX
SCLX
Q4 25
-70.8%
-2317.8%
Q3 25
-1766.2%
Q2 25
-53.6%
-207.2%
Q1 25
-557.5%
Q4 24
-190.5%
Q3 24
-138.0%
Q2 24
-95.4%
Q1 24
-179.0%
Net Margin
DOGZ
DOGZ
SCLX
SCLX
Q4 25
-67.1%
-961.9%
Q3 25
-2441.5%
Q2 25
-47.9%
-445.1%
Q1 25
-521.2%
Q4 24
-43.4%
Q3 24
-30.4%
Q2 24
-229.6%
Q1 24
-224.0%
EPS (diluted)
DOGZ
DOGZ
SCLX
SCLX
Q4 25
$-0.29
$-4.63
Q3 25
$-22.17
Q2 25
$-7.42
Q1 25
$-2.26
Q4 24
$8.53
Q3 24
$-0.58
Q2 24
$-7.67
Q1 24
$-8.33

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DOGZ
DOGZ
SCLX
SCLX
Cash + ST InvestmentsLiquidity on hand
$6.6M
$5.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$95.1M
$-207.8M
Total Assets
$114.5M
$365.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DOGZ
DOGZ
SCLX
SCLX
Q4 25
$6.6M
$5.0M
Q3 25
$878.0K
Q2 25
$12.8M
$4.1M
Q1 25
$5.8M
Q4 24
$3.3M
Q3 24
$77.0K
Q2 24
$6.9M
Q1 24
$1.8M
Stockholders' Equity
DOGZ
DOGZ
SCLX
SCLX
Q4 25
$95.1M
$-207.8M
Q3 25
$-176.9M
Q2 25
$97.8M
$-249.0M
Q1 25
$-211.5M
Q4 24
$-192.6M
Q3 24
$-211.3M
Q2 24
$-214.7M
Q1 24
$-189.8M
Total Assets
DOGZ
DOGZ
SCLX
SCLX
Q4 25
$114.5M
$365.0M
Q3 25
$275.9M
Q2 25
$116.8M
$83.8M
Q1 25
$79.0M
Q4 24
$93.0M
Q3 24
$100.4M
Q2 24
$104.5M
Q1 24
$91.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DOGZ
DOGZ
SCLX
SCLX
Operating Cash FlowLast quarter
$-1.6M
$-17.5M
Free Cash FlowOCF − Capex
$-6.0M
FCF MarginFCF / Revenue
-77.8%
Capex IntensityCapex / Revenue
56.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DOGZ
DOGZ
SCLX
SCLX
Q4 25
$-1.6M
$-17.5M
Q3 25
$8.2M
Q2 25
$7.0M
Q1 25
$6.0M
Q4 24
$2.5M
Q3 24
$5.1M
Q2 24
$2.3M
Q1 24
$9.4M
Free Cash Flow
DOGZ
DOGZ
SCLX
SCLX
Q4 25
$-6.0M
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
FCF Margin
DOGZ
DOGZ
SCLX
SCLX
Q4 25
-77.8%
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
DOGZ
DOGZ
SCLX
SCLX
Q4 25
56.9%
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.0%
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons